Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT04861051
PHASE1
Understanding Ketamine's Dissociative Effects (KD Study)
Sponsor: Stanford University
View on ClinicalTrials.gov
Summary
The purpose of this study is to understand how ketamine brings about dissociative symptoms.
Official title: Understanding Ketamine's Dissociative Effects in Epilepsy (KD Study)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2021-07-26
Completion Date
2028-08-01
Last Updated
2024-09-26
Healthy Volunteers
No
Conditions
Interventions
DRUG
Ketamine
Study participants will receive 0.5mg/kg of ketamine - one single infusion
Locations (1)
Stanford University School of Medicine
Palo Alto, California, United States